{"id":80277,"date":"2025-05-06T21:35:09","date_gmt":"2025-05-06T21:35:09","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/80277\/"},"modified":"2025-05-06T21:35:09","modified_gmt":"2025-05-06T21:35:09","slug":"32-000-boites-de-lisinopril-rappelees-en-france","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/80277\/","title":{"rendered":"32.000 bo\u00eetes de Lisinopril rappel\u00e9es en France"},"content":{"rendered":"

L\u2019inscription pr\u00e9sente sur \u00abl\u2019aluminium de la plaquette peut pr\u00eater \u00e0 confusion\u00bb sur la posologie, justifie l\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament.<\/p>\n

Plus de 32.000 bo\u00eetes d’un m\u00e9dicament g\u00e9n\u00e9rique contre l’hypertension et\u00a0l’insuffisance cardiaque<\/a>, le Lisinopril, ont \u00e9t\u00e9 rappel\u00e9es en France en raison d’un \u00abd\u00e9faut d’impression\u00bb sur les plaquettes \u00abpouvant induire un risque de surdosage\u00bb, a indiqu\u00e9 mardi l’Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament (ANSM). La qualit\u00e9 des comprim\u00e9s commercialis\u00e9s par le laboratoire am\u00e9ricain Viatris \u00abn’est pas remise en cause\u00bb mais \u00abl’inscription pr\u00e9sente sur l’aluminium de la plaquette peut pr\u00eater \u00e0 confusion car elle laisse penser qu’il faut prendre plusieurs comprim\u00e9s certains jours\u00bb, pr\u00e9cise l’ANSM dans un communiqu\u00e9.<\/p>\n

Au total, quatre lots de Lisinopril dos\u00e9s \u00e0 5 mg sont concern\u00e9s (lots 8172295, 8189879, 8172296, 8192737), soit 32.640 bo\u00eetes, selon un d\u00e9compte obtenu aupr\u00e8s de l’ANSM. En cas de surdosage, il est possible de ressentir de la fatigue, des troubles de l’\u00e9quilibre, une hypotension et \u00abune alt\u00e9ration de la fonction r\u00e9nale peut survenir\u00bb, pr\u00e9vient la gardienne du m\u00e9dicament.<\/p>\n

Un cas de surdosage accompagn\u00e9 d’un \u00e9tat confusionnel non grave a \u00e9t\u00e9 rapport\u00e9, selon l’ANSM. En attendant que de nouveaux lots avec des plaquettes conformes soient \u00abprochainement disponibles\u00bb, aucune tension d’approvisionnement en Lisinopril n’est pr\u00e9vue \u00e0 la suite de ce rappel, selon l’agence, car \u00abdes alternatives sont disponibles\u00bb. D’autres g\u00e9n\u00e9riqueurs, comme Biogaran, Teva, Zentiva, Sandoz ou Arrow proposent cette mol\u00e9cule, selon la base de donn\u00e9es Vidal sur les m\u00e9dicaments en France.<\/p>\n","protected":false},"excerpt":{"rendered":"L\u2019inscription pr\u00e9sente sur \u00abl\u2019aluminium de la plaquette peut pr\u00eater \u00e0 confusion\u00bb sur la posologie, justifie l\u2019Agence nationale de…\n","protected":false},"author":2,"featured_media":80278,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[237,11,101,232,231,234,228,1011,27,239,230,238,226,224,225,12,233,229,236,235,25,71,227],"class_list":{"0":"post-80277","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-france","8":"tag-actualite-sur-les-maladies","9":"tag-actualites","10":"tag-cancer","11":"tag-cardiologie","12":"tag-cerveau","13":"tag-diabete","14":"tag-diagnostic","15":"tag-fr","16":"tag-france","17":"tag-info-sur-les-maladies","18":"tag-infographie","19":"tag-information-sur-les-maladies","20":"tag-maladie","21":"tag-medecine","22":"tag-medicament","23":"tag-news","24":"tag-obesite","25":"tag-pathologie","26":"tag-pediatrie","27":"tag-psychiatrie","28":"tag-republique-francaise","29":"tag-sante","30":"tag-traitement"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114463042668216609","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/80277","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=80277"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/80277\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/80278"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=80277"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=80277"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=80277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}